Clinical Trial

Safety, Efficacy and Pharmacokinetic Characteristics of KR230109 Cream in Facial Acne Vulgaris

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This study will evaluate the safety, efficacy and pharmacokinetics of KR230109 cream compared with placebo in Patients (18-40 Years) with Acne vulgaris
Trial Details
NCT Number NCT07345390
Lead Sponsor Jiangxi Kvvit Pharmaceutical Co., Ltd.
Conditions Acne Vulgaris
Enrollment 180 participants
Start Date 2026-01-10
Primary Completion 2026-10-30 (estimated)
Study Completion 2026-11-30 (estimated)
Updated on ClinicalTrials.gov 2026-01-15